Skip to main content

Table 2 Percentage and Incidence of Combined Resistance Phenotypes, Israel, 2014–2017

From: Trends in antimicrobial resistance in Israel, 2014–2017

 

2014

2015

2016

2017

Bacterial name

Percentage of resistant isolates

Incidence per 100,000 patient-days

Percentage of resistant isolates

Incidence per 100,000 patient-days

Percentage of resistant isolates

Incidence per 100,000 patient-days

Percentage of resistant isolates

Incidence per 100,000 patient-days

A. baumannii Carb+FQ + AG

73.2

8.4

74.2

9.3

72.2

7.8

70.1

7.2

E. coli 3GC

29.5

24.1

32.0

30.2

32.4

32.3

32.0

32.4

E. coli 3GC + FQ + AG

10.6

8.7

10.3

9.7

9.3

9.1

8.3

8.2

K. pneumoniae 3GC + FQ + AG

23.7

8.0

20.8

7.6

20.7

8.3

19.2

8.0

K. pneumoniae Carb+Col

1.8

0.2

0.6

0.0

0.4

0.0

ND

ND

  1. AG Aminoglycoside-resistant, Carb Carbapenem-resistant, Col Colistin-resistant, FQ Fluoroquinolone-resistant, 3GC 3rd-generation cephalosporin-resistant